Epidemiological and virological surveillance of mumps, Spain 2005-2022
DOI:
https://doi.org/10.4321/s2173-92772023000300001Keywords:
mumps; surveillance; epidemiology; vaccines; laboratory diagnosis; molecular epidemiology, RT-PCR; SpainAbstract
Introduction: mumps is a common disease, which continues to cause outbreaks even in well-vaccinated vaccinated populations. The objective is to describe the surveillance of mumps in Spain. We present the analysis of cases reported to RENAVE (National epidemiological surveillance network) between 2005 and 2022 and the results of the mumps microbiological surveillance programme (PVMP) of the CNM (National Center of Microbiology) between 2016 and 2021. The completion of the variables and the integration of laboratory information in the reported cases are analysed.
Method: Sources: cases reported to RENAVE and cases and samples from the CNM’s PVMP. Cases are analysed by year, autonomous community, sex and age, type of case, vaccination and laboratory data. Annual and period rates are calculated. Samples and determinations are analysed for PVMP.
Results: Three epidemic waves are described: 2005-2009, 2010-2014 and 2015-2020. Incidence was minimal in 2021, recovering slightly in 2022. Mumps mainly affects adolescents and young adults. 32% of cases are vaccinated with two doses. Only 48% of investigated cases are confirmed. Saliva has the best PCR positivity rate. Completion is adequate for sociodemographic variables, low for vaccination and very low for severity. Information on laboratory studies performed in CNM is generally, not reported to RENAVE.
Conclusions: Mumps is a common disease that should be monitored. All information generated in surveillance activities should be integrated into a single system devoted for public health action.
Downloads
References
Lam E, Rosen JB, Zucker JR. 2020. Mumps: an update on outbreaks, vaccine efficacy, and genomic diversity. Clin Microbiol Rev 33:e00151-19. DOI: 10.1128/CMR.00151-19
Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Red Nacional de Vigilancia Epidemiológica. Protocolos de enfermedades de declaración obligatoria. [Internet]. 2013. Disponible en: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/PROTOCOLOS/PROTOCOLOS%20EN%20BLOQUE/PROTOCOLOS_RENAVE-ciber.pdf
ECDC. Mumps. A-Z list diseases [Internet]. Disponible en: https://www.ecdc.europa.eu/en/mumps
WHO. Mumps virus nomenclature update: 2012. Wkly Epidemiol Rec. 2012 Jun 1;87(22):217-24.
Jin L, Örvell C, Myers R, Rota PA, Nakayama T, Forcic D, et al. Genomic diversity of mumps virus and global distribution of the 12 genotypes. Rev Med Virol. 2015;25(2):85-101. DOI: 10.1002/rmv.1819
Echevarría Mayo, Juan Emilio; Oteo Iglesias, Jesús (Editores). Centro Nacional de Microbiología. Programas de Vigilancia Microbiológica. Madrid: Instituto de Salud Carlos III; 2021.
Parotiditis. Enfermedades A-Z. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. [Internet]. Disponible en: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Paginas/Parotiditis.aspx
Consejo Interterritorial del Sistema Nacional de Salud. Calendario Común de Vacunación a lo largo de toda la vida. Año 2023 [Internet]. Disponible en: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/calendario-y-coberturas/docs/CalendarioVacunacion_Todalavida.pdf
Pons C, Pelayo T, Pachon I, Galmes A, Gonzalez L, Sanchez C, et al. Two outbreaks of mumps in children vaccinated with the Rubini strain in Spain indicate low vaccine efficacy. Euro Surveill. 2000;5(7):80-4. DOI: 10.2807/esm.05.07.00014-en
Castilla J, García Cenoz M, Barricarte A, Irisarri F, Núñez-Córdoba JM, Barricarte A. Mumps outbreak in Navarre region, Spain, 2006-2007. Euro Surveill. 2007;12(2):E070215.1. DOI: 10.2807/esw.12.07.03139-en
Ministerio de Sanidad. Sistema de Información de Vacunaciones (SIVAMIN) [Internet]. [citado 11 de julio de 2023]. Disponible en: https://pestadistico.inteligenciadegestion.sanidad.gob.es/publicoSNS/S/sivamin
López-Perea N, Masa-Calles J, Torres de Mier M de V, Fernández-García A, Echevarría JE, De Ory F, et al. Shift within age-groups of mumps incidence, hospitalizations and severe complications in a highly vaccinated population. Spain, 1998-2014. Vaccine. 2017;35(34):4339-45. DOI: 10.1016/j.vaccine.2017.06.075
Gavilán AM, Van De Nes-Reijnen L, Castellanos A, Woudenberg T, López-Perea N, Masa-Calles J, et al. Comparison of circulation patterns of mumps virus in the Netherlands and Spain (2015–2020). Front Microbiol. 2023;14:1207500. DOI: 10.3389/fmicb.2023.1207500
Gavilán AM, Díez-Fuertes F, Sanz JC, Castellanos AM, López-Perea N, Jiménez SM, et al. Increase of diversity of mumps virus genotype G SH variants circulating among a highly immunized population: Spain, 2007-2019. J Infect Dis. 2022;jiac176. DOI: 10.1093/infdis/jiac176
Consejo Interterritorial del Sistema Nacional de Salud. 2o Estudio de Seroprevalencia de las enfermedades inmunoprevenibles y otras [Internet]. 2020 [citado 17 de marzo de 2021]. Disponible en: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/comoTrabajamos/docs/EstudioSeroprevalencia_EnfermedadesInmunoprevenibles.pdf
Castilla J, García Cenoz M, Arriazu M, Fernández-Alonso M, Martínez-Artola V, Etxeberria J, et al. Effectiveness of Jeryl Lynn-containing vaccine in Spanish children. Vaccine. 2009;27(15):2089-93. DOI: 10.1016/j.vaccine.2009.02.001
Cardemil CV, Dahl RM, James L, Wannemuehler K, Gary HE, Shah M, Marin M, Riley J, Feikin DR, Patel M, Quinlisk P. Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control. N Engl J Med. 2017 Sep 7;377(10):947-956 DOI: 10.1056/NEJMoa1703309
Hiebert J, Saboui M, Frost JR, Zubach V, Laverty M, Severini A. Mumps resurgence in a highly vaccinated population: Insights gained from surveillance in Canada, 2002-2020. Vaccine. 2023;S0264-410X(23)00513-3. DOI: 10.1016/j.vaccine.2023.04.078
Su SB, Chang HL, Chen AKT. Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine. Int J Environ Res Public Health. 2020;17(5):1686. DOI: 10.3390/ijerph17051686
Centro Nacional de Epidemiología. CIBERESP. ISCIII. Informe epidemiológico sobre la situación de la parotiditis en España, 2005-2021. Madrid, abril 2023. Disponible en: : https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/archivos%20A-Z/PAROTIDITIS/Informe_Parotiditis_Espa%C3%B1a_2005-2021.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Almudena Horcas de Frutos, Noemí López-Perea, Aurora Fernández-García, Ana M Gavilán , Juan E. Echevarría , David Olivares-Quintanar, Josefa Masa-Calles
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
El material creado por un autor puede ser distribuido, copiado y exhibido por terceros si se hace referencia a la autoría. No se puede obtener ningún beneficio comercial y las obras derivadas tienen que estar bajo los mismos términos de licencia que el trabajo original
